Skip to main content
Start of main content.

Cochrane Acute Respiratory Infections (ARI) Group

About Cochrane

Cochrane is an international, not-for-profit collaboration of 26 Review Groups, 12 Thematic Groups, and 5 Evidence Synthesis Units producing comprehensive systematic reviews on a broad range of health topics. Reviews are prepared by healthcare professional volunteers who work with Cochrane Review Groups. The editorial teams of these Groups oversee the preparation and maintenance of the reviews. Cochrane reviews have become internationally acknowledged as the pre-eminent rigorous quality standard for systematic reviews. Cochrane was founded in 1993 and named after the British epidemiologist, Archie Cochrane. Our major product is the Cochrane Database of Systematic Reviews which is published as part of the Cochrane Library. The activities of Cochrane are directed by an elected Governing Board and supported by staff in Cochrane Groups (Centres, Review Groups, Methods Groups, Fields/Networks) around the world.

Further reading

 

Cochrane ARI Group LOGO

Cochrane Acute Respiratory Infections (ARI) Review Group 

The Cochrane Acute Respiratory Infections (ARI) Review Group was registered on 17 August 1994, following an exploratory meeting on 26 May 1994, in Baltimore, USA. The Cochrane ARI editorial base relocated from Canberra to Brisbane in 2001, and to Bond University in 2004. The group is funded by the Australian National Health and Medical Research Council (NHMRC). Cochrane ARI editorial staff support authors through the editorial process from title registration to review updating. These processes include editorial and technical support, statistical input, rigorous refereeing, and working to deadlines to produce high quality systematic reviews for publication on the Cochrane Library. Our main goals are to enhance healthcare quality worldwide and provide timely evidence to guide clinical and policy health care decisions. The team comprises clinical experts, statisticians, and a Managing Editor.

Follow us

Editorial team

  • A/Professor Mark Jones (Co-ordinating Editor), Institute for Evidence-Based Healthcare, Bond University, Australia
  • Professor Mieke L van Driel (Deputy Co-ordinating Editor), Primary Care Clinical Unit, Faculty of Medicine, The University of Queensland, Australia
  • Liz Dooley (Managing Editor), Institute for Evidence-Based Healthcare, Bond University, Australia
  • Dr Lubna Al-Ansary, Department of Family and Community Medicine, College of Medicine, King Saud University, Riyadh
  • Dr Allen C Cheng, Department of Epidemiology and Preventive Medicine, Monash University, Australia
  • Prof Roger AMJ Damoiseaux, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Netherland
  • Prof Paul P Glasziou AO, Institute for Evidence-Based Healthcare, Bond University, Australia
  • A/Prof Michelle Guppy, School of Rural Medicine, University of New England, Australia
  • Prof Carl J Heneghan, Nuffield Department of Primary Care Health Sciences, University of Oxford, UK
  • Menelaos Konstantinidis, Institute of Health Policy, Management and Evaluation, University of Toronto, Canada
  • Prof Tom Jefferson, Department of Continuing Education, University of Oxford, UK
  • Dr Zohra Lassi, The Robinson Research Institute, The University of Adelaide, Australia
  • Prof Paul Little, Primary Care and Population Sciences, Faculty of Medicine, University of Southampton, UK
  • Dr Nader Sheikh, General Academic Pediatrics, Children's Hospital of Pittsburgh, USA
  • Dr Meenu Singh, Department of Pediatrics, Post Graduate Institute of Medical Education and Research, India
  • Prof Susan M Smith, Department of Public Health and Primary Care, Trinity College Dublin, Ireland
  • A/Prof Johannes C van der Wouden, Departments of General Practice and Medicine for Older People, Amsterdam University Medical Center, Netherlands
  • Dr Roderick P Venekamp, Department of General Practice and Nursing Science, Julius Center for Health Sciences and Primary Care, Utrecht University, Netherlands
  • Prof S Rob Ware, Menzies Health Institute Queensland, Griffith University, Australia

Scope of our work

We use evidence ostensibly from randomised controlled trials to answer practical questions on the prevention, treatment, and diagnostic test accuracy of acute respiratory infections. This includes interventions to prevent and treat acute respiratory infections including acute otitis media (middle ear infection), bronchiolitis, bronchitis, chickenpox, common cold, COVID, croup, diphtheria, glandular fever, influenza, laryngitis, Legionnaire’s disease, measles, meningitis, mumps, pneumonia, polio, respiratory syncytial virus, rubella, SARS, shingles, sinusitis, sore throat (pharyngitis and tonsillitis), and whooping cough. To see the titles of our published protocols and reviews please visit our website.

Our reviews

Our Members and Supporters

Cochrane's Members and Supporters come from many different backgrounds and from countries all around the world. They are volunteers, health professionals, authors, translators, patients and carers and Cochrane staff. They all have one thing in common: they dedicate their time and skills to producing and promoting Cochrane evidence and to supporting our community. 

How many Members and Supporters are there?